Trigyn Technologies Reports Strong Q2 FY25 Consolidated Results, Appoints New CS
Trigyn Technologies reported robust Q2 FY25 consolidated results with significant profit growth. The board approved financial statements and appointed Mr. Anmol Chaturvedi as the new Company Secretary.
The announcement of strong quarterly financial results, particularly the significant profit turnaround, is a key driver for stock performance and investor confidence. The management changes and auditor's notes, while important, are secondary to the positive financial performance for immediate market impact.
The company reported strong financial performance with a substantial increase in consolidated revenue and a significant turnaround to net profit in Q2 FY25 compared to previous periods. The appointment of a new Company Secretary ensures continuity in key management functions. While there are cautionary notes from auditors and ongoing legal matters, the strong financial results are a dominant positive factor.
* Trigyn Technologies Limited's Board of Directors, in a meeting held on November 13, 2025, approved the Unaudited Financial Results (Standalone and Consolidated) for the second quarter and half year ended September 30, 2025. * For the second quarter ended September 30, 2025, the company reported consolidated revenue from operations of ₹24,195.14 lakhs. * The consolidated net profit for the period stood at ₹527.21 lakhs, with basic earnings per equity share of ₹1.71. * The Board noted the resignation of Mrs. Prachi Deshpande as Company Secretary and Compliance Officer, effective November 13, 2025, citing personal and professional opportunities. * Mr. Anmol Chaturvedi (ACS No. A73871) was appointed as the new Company Secretary & Compliance Officer, effective from November 14, 2025. * The auditor's limited review report highlighted several matters without qualifying the opinion, including the non-accounting of ₹80 crore guaranteed revenue due to collection uncertainty, an unamortized capital cost of ₹3.97 crore for a terminated toll collection project, and ongoing legal suits. * The auditor also noted the preparation of financial statements for two subsidiaries (Leading Edge Infotech Limited and Trigyn Technologies India Private Limited) on a going concern basis despite negative net worth, relying on support from the holding company. * A show cause cum demand notice of ₹9.08 crores from the GST department for disallowing Input Tax Credit for FY 2019-20 to FY 2022-23 is pending before the Joint Commissioner. * Upcoming trial dates for a civil litigation case are scheduled for February 3-5, 2026; March 12, 2026; March 30-31, 2026; April 1-2, 2026; and April 6-7, 2026.
What to do with a filing like this
Trigyn Technologies Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Trigyn Technologies Limited. Read the original for the full detail.